---
citekey: bouchouras2025
---

[[@bouchouras2025]]

## üìñ Summary

### Objective/Purpose

- The main goal of the review is to examine how artificial intelligence (AI), Internet of Things (IoT), and sensor-based technologies are integrated into autism spectrum disorder (ASD) detection.
- It aims to answer how these emerging technologies can improve early diagnosis, provide objective assessments, and overcome limitations of traditional diagnostic approaches.

### Scope of the Review

- Covers AI-driven diagnostic tools, wearable sensors, neuroimaging, eye-tracking, virtual reality, and microbiome analysis.
- Focuses on methodologies, accuracy, and effectiveness in detecting ASD markers.
- **Type:** Systematic review.

### Key Inclusion Criteria

|Inclusion Criteria|Details|
|---|---|
|**Study Types**|Empirical studies, experimental research, clinical trials, and technical evaluations of AI, IoT, and sensor-based ASD detection.|
|**Participants**|Studies involving children and adults with ASD, typically developing (TD) controls.|
|**Technologies Covered**|AI models (ML/DL), IoT devices, EEG, fMRI, wearable sensors, eye-tracking, VR, microbiome analysis.|
|**Publication Types**|Peer-reviewed journals, conference proceedings.|
|**Languages**|English.|

### Key Exclusion Criteria

|Exclusion Criteria|Details|
|---|---|
|**Study Types**|Meta-analyses, literature reviews, opinion pieces, short communications.|
|**Participant Demographics**|Studies focusing solely on non-ASD conditions without ASD relevance.|
|**Incomplete Data**|Studies without full methodological descriptions or results.|
|**Non-Peer Reviewed Sources**|Grey literature, preprints without peer review.|

---

## üî¨ Methods

### Study Selection & Data Sources

|Database|Search Terms Used|Studies Retrieved|
|---|---|---|
|PubMed|"AI AND IoT AND ASD diagnosis"|175|
|ScienceDirect|"Sensor-based ASD detection"|101|
|ACM Digital Library|"Autism AND wearable sensors AND AI"|35|
|Scopus|"Machine learning for ASD detection"|39|
|**Total**|**-**|**350**|


### Data Extraction & Quality Assessment

- Data extracted by **two independent reviewers** using standardized spreadsheets.
- **Risk of Bias Assessment:** Cochrane Risk of Bias tool (for RCTs), ROBINS-I (for observational studies).

### Meta-Analysis Methods (if applicable)

- **Statistical techniques:** Random effects model, subgroup analysis, meta-regression.
- **Heterogeneity assessment:** I¬≤ statistic, Cochran‚Äôs Q test.

---

## üìä Results & Key Findings

### Overview of Included Studies

|Parameter|Summary|
|---|---|
|**Total Studies Included**|30|
|**Sample Size Range**|50 - 500 participants per study|
|**Study Designs**|RCTs, observational, case-control, longitudinal studies|
|**Geographical Distribution**|North America, Europe, Asia|

### Main Findings

- **Primary Outcomes & Effect Sizes:**
    
    - AI models achieved high accuracy in ASD detection (80‚Äì95%).
    - Wearable sensors provided continuous monitoring and real-time behavioral tracking.
    - Eye-tracking studies identified distinct gaze patterns with 85‚Äì90% classification accuracy.
    - Neuroimaging and microbiome analysis offered biomarkers for ASD.
- **Heterogeneity & Publication Bias:**
    
    - Significant heterogeneity (I¬≤ > 60%) observed across studies.
    - No major publication bias detected (Egger‚Äôs test p > 0.05).

---

## üîç Related Work & Theoretical Framework

- Compared with previous reviews, this study expands on real-time AI applications in ASD diagnosis.
- References **biopsychosocial models** integrating behavior, physiology, and neural markers.

---

## üìù Observations

### Strengths of the Study

‚úÖ **Comprehensive scope with AI, IoT, and sensor-based technologies**  
‚úÖ **Robust methodology using systematic search and bias assessment**  
‚úÖ **Inclusion of diverse data sources (EEG, eye-tracking, neuroimaging, microbiome)**  
‚úÖ **Real-time and non-invasive diagnostics improving accessibility**

### Major Concerns & Limitations

‚ö†Ô∏è **Potential publication bias due to emerging AI studies**  
‚ö†Ô∏è **High heterogeneity across study methodologies**  
‚ö†Ô∏è **Need for validation of AI models in clinical settings**  
‚ö†Ô∏è **Limited generalizability in some studies (small sample sizes, specific regions)**

---

## üöÄ Conclusion & Future Directions

### Summary of Implications

- AI, IoT, and sensor-based methods **enhance ASD diagnosis** with real-time, non-invasive approaches.
- Potential to **reduce reliance on behavioral observation** and **increase early detection**.
- Need for **standardized datasets and regulatory frameworks** to integrate AI tools into clinical practice.

### Gaps Identified & Future Research Directions

- Larger, multi-center trials needed to **validate AI-driven ASD diagnostics**.
- Ethical concerns around **data privacy, bias, and transparency**.
- Development of **hybrid diagnostic models combining AI with traditional assessments**.

